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Abstract – Francisella tularensis is a gram-negative coccobacillus and the etiologic agent of the
zoonotic disease tularemia. First described in 1911 in Tulare County, California, it has since been
reported throughout the Northern Hemisphere, with natural infections reported among an unusually
wide range of vertebrates and invertebrates. In recent years, tularemia has emerged in new
geographic locations, populations, and settings. This review will serve to highlight mechanisms
contributing to the recent emergence of tularemia as well as a repertoire of diagnostic tools useful
for detecting and diagnosing disease. 
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1. HISTORY
Tularemia is a zoonotic disease caused by
the small, gram-negative bacterium, Fran-
cisella tularensis, one of the most infectious
bacteria known, with < 10 organisms capa-
ble of causing severe disease in both humans
and animals [23, 60]. First described as a
disease of significance nearly a century ago,
tularemia has recently emerged in areas with
no previous known risk and re-emerged in
research and public health circles due to its
biothreat potential. 
The complexity of F. tularensis and its
associated disease can be illustrated by a
brief review of the early history. In 1911,
McCoy and Chapin described a plague-like
illness of rodents in Tulare County, Califor-
nia, and soon after (1912) cultured F. tula-
rensis from squirrels in the area [49]. Two
years later, the first human illness attributed
to F. tularensis was described by Wherry
and Lamb in Ohio, who isolated the bacte-
rium from two patients with confirmed wild
rabbit contact [68]. Subsequently, Edward
Francis, for whom the genus is named,
established that several clinical syndromes
throughout the United States were caused
by F. tularensis and proposed the name
“tularemia” to describe them [29, 30]. These
syndromes included “rabbit fever”, “market’s
men disease” and “meat-cutter’s disease”,
all of which were used to describe the illness
associated with dressing rabbits for meat.
“Deer-fly fever” was used to describe the
disease following a deerfly bite, with most
early observations made by Pierce in Utah.
“Glandular type of tick fever” was used by
physicians in Idaho who noted enlargement
of lymph nodes in response to a tick bite.
Until 1925, it was widely believed that
tularemia was a disease with risk limited to the
United States. This perception soon changed.
Ohara, studying hare disease (Yato-byo) in
Japan, recognized the similarity of the disease
to tularemia and sent specimens to Francis,
who confirmed the presence of F. tularensis
[52]. In the USSR (1928), F. tularensis was
recognized as the causative agent of “water-
rat-trappers’ disease”, an illness acquired by
trappers who skinned water-rats for their pelts
[62, 71]. Soon thereafter, tularemia was also
reported in Norway (1929), Canada (1930),
Sweden (1931) and Austria (1935) [31]. 
2. EPIDEMIOLOGY
Today, tularemia is recognized as a widely
dispersed disease throughout the Northern
Hemisphere with foci in certain parts of
North America, Europe, and northern Asia
[23, 43]. Few, if any, zoonotic diseases have
a broader or more complex host distribution
and epizootiology. F. tularensis infection
has been evidenced in a staggering number
of wildlife species including various lago-
morphs, rodents, insectivores, carnivores,
ungulates, marsupials, birds, amphibians, fish
and invertebrates [8, 42, 43, 50]. Arthro-
pods, including ticks, biting flies, and pos-
sibly mosquitoes, serve as vectors and poten-
tially, long-term reservoirs [8, 24, 42, 44,
50]. Despite the complexity of the global
picture of tularemia, the main components
of regional disease cycles are much more
narrow, typically involving only one to a
few, key mammalian and arthropod species.
Two disease cycles, terrestrial and aquatic,
have been described [44, 50]. In the terres-
trial cycle, rabbits and hares typically serve
as amplifying hosts and ticks or biting flies
are arthropod vectors. In the aquatic cycle,
beaver, muskrat and voles serve as impor-
tant mammalian hosts and appear to shed
live organisms into their environments. In
Sweden, mosquitoes have been strongly
implicated as vectors of tularemia and may
acquire infection from other components of
the aquatic cycle. Curiously, mosquitoes
are not thought to be significant contribu-
tors to disease transmission in the United
States, despite their sharing of the same
environments as other components of the
aquatic system. Recently, protozoa have been
shown to harbor F. tularensis and may play
an important role in aquatic cycles [1]. The
interaction between aquatic and terrestrial
cycles is largely unknown.
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F. tularensis has been classified into four
distinct subspecies, tularensis, holarctica,
mediasiatica, and novicida [60]. The global
distribution of disease caused by each sub-
species is shown in Figure 1; clearly, subsp.
tularensis and holarctica are responsible
for the majority of described human and
animal illness. Of the four subspecies, subsp.
tularensis, also known as Type A, has the
highest mortality rate. Infections due to
Type A have been limited to North America.
In comparison, F. tularensis subsp. holarc-
tica, also known as Type B, has been doc-
umented throughout the Northern Hemi-
sphere. Thus, in North America, both
Type A and Type B are present and often
over-lap within a given sub-region. The
subsp. novicida and mediasiatica have
more focal distributions with mediasiatica
isolated only from the Central Asian
regions of the former USSR, and novicida
isolated from North America and more
recently Australia [18, 41, 60, 69]. These two
subspecies are infrequently associated with
human disease. 
Risk factors associated with human dis-
ease are linked to local disease ecology. For
example, in the Western United States, bit-
ing fly exposures, tick bites and animal con-
tact are all significant risks factors [43, 44].
In contrast, human cases in the central
United States are rarely linked with biting
flies and most often associated with tick bites
and animal exposure [43, 44]. Similarly,
mosquito exposure is an important risk fac-
tor in Sweden, whereas tabanid exposure is
more strongly linked to cases in Russia [8]. 
Clinical presentation of tularemia is varia-
ble and dependent on the route of infection
[22, 23]. Presentations include ulceroglandu-
lar, glandular, oculoglandular, oropharyn-
geal, pneumonic and typhoidal forms of
tularemia. Ulceroglandular tularemia gen-
erally arises from contact with an infected
animal or by the bite of an infected vector
and is characterized by the presence of an
ulcerated lesion and enlargement of regional
lymph nodes. This type of exposure is exem-
plified by cases in a recent outbreak in Spain
(described below). Glandular tularemia is
quite similar to ulceroglandular disease but
lacks the ulcerated site of infection. Ocu-
loglandular tularemia occurs when the
conjunctiva is the initial site of infection,
usually a result of mechanical transfer of
organisms from an infectious source to the
eye by the fingers. This form of disease is
characterized by the appearance of ulcers and
nodules on the conjunctiva and regional lymph
node swelling. Oropharyngeal tularemia
results from ingestion of contaminated water
or food and is characterized by a severe sore
throat with enlargement of the tonsils and
swollen cervical lymph nodes. Most human
cases in the recent outbreak of tularemia in
Kosovo (described below) were of this
form. Pneumonic tularemia, the most severe
form of disease, occurs by direct inhalation
of the organism, or may develop secondar-
ily by septicemic spread of infection from
a primary site of infection. Historically, farm-
ing, and more recently landscaping, have
been significant occupational risk-factors
associated with pneumonic tularemia in
certain endemic areas [26, 63]. Typhoidal
tularemia is used to describe a systemic dis-
ease with fever and other constitutional signs
in the absence of lymphadenitis, cutaneous
lesions, or primary pulmonary involvement. 
3. NATURAL EMERGENCE 
AND ASSOCIATED FACTORS
Perhaps Roy Parker best voiced the poten-
tial for emergence of tularemia when he
said: “I know of no other infection of ani-
mals communicable to man that can be
acquired from sources so numerous and so
diverse. In short, one can but feel that the
status of tularemia, both as a disease in
nature and of man, is one of potentiality”
[54]. With F. tularensis being so wide-
spread in wildlife species and the environ-
ment, it is poised to appear in new places
and populations at any time.
As examples of natural emergence or re-
emergence of tularemia, three outbreaks
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Figure 1. The global distribution of disease caused by F. tularensis subspecies. The different shadings represent the dis-
tributions of Type A and Type B ( ), Type B ( ), novicida ( ), and mediasiatica ( ). Note that in North America, disease
is caused by both subsp. Type A and Type B.
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and an isolated case will be highlighted in
this review (Tab. I) and include: the first
evidence of tularemia in Spain (1997) and
in Kosovo (2000), the first large-scale out-
break of tularemia in prairie dogs (United
States, 2002), and the finding of F. tularen-
sis in the Southern Hemisphere (2002).
While other examples of tularemia emer-
gence exist, the cases detailed here serve to
highlight a variety of mechanisms for dis-
ease emergence.
3.1. Spain (1997)
 Although tularemia has been reported
throughout much of Europe, it first emerged
as a human disease in Spain in 1997–1998,
when a large outbreak occurred [21, 37, 55].
A total of 559 cases of tularemia were reported
with 519 cases from the community of Cas-
tille-Leon in northwestern Spain. A study
of 142 patients in this region indicated that
97.2% had previous contact with hares;
83.8% had prepared hare carcasses and 13.3%
had handled hare meat [55]. As expected
based on contact with infected animals,
ulceroglandular tularemia was the most
common form of clinical disease observed
(87% of patients). Type B was isolated from
patients and also from hares in the region. 
In 1998, a second outbreak of tularemia
in humans was reported, this time in the
central province of Cuenca, a region distant
from the outbreak the previous year [4].
Nineteen cases of ulceroglandular tularemia
were identified in persons who had contact
with crayfish. This outbreak was most unu-
sual in that tularemia had not previously
been associated with fishing. Waterborne
outbreaks of tularemia have occurred in the
past, but most have been associated with
contaminated drinking water [35, 43]. Tran-
sient contamination of the river and crayfish
was implicated as the cause of the outbreak,
with most patients incurring crayfish-related
scratches, cuts, and abrasions while fishing.
A sewage plant, which intermittently dis-
charged water into the river, was linked to
the cause of the outbreak. Type B, PCR pos-
itive samples were obtained from the river,
crayfish, and human lymph node aspirates.
It is not clear when tularemia was intro-
duced into Spain. Since tularemia was not
recognized as a disease of Spain it would
not have been considered in a clinical diag-
nosis prior to 1997. Nonetheless, evidence
suggests that F. tularensis was present in
Spain before the first outbreak. Retrospec-
tive studies have shown the presence of
anti-F. tularensis antibodies in humans prior
to 1997 and tularemia as the cause of a large
hare die-off in the Castille-Leon area in
1994 [27, 34, 37].
The basis for emergence of tularemia in
Spain remains speculative, with a likely
explanation that infected hares were imported
Table I. Emergence of naturally occurring F. tularensis (1997–2002).
Site of emergence Subspecies Year Source of infection Likely basis for emergence
Spain
(Humans)
holarctica 1997
1998 
Hares
Crayfish 
Importation of hares from 
endemic countries
Kosovo
(Humans)
holarctica 2000  Food and water War conditions/rodent 
population increase
United States
(Prairie Dogs)
holarctica 2002 Prairie dogs Exotic Pet trade/unregulated 
commercial sales of wild-caught 
animals
Australia
(Human)
novicida 2002 Water Enhanced detection/
laboratory skills 
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from tularemia endemic countries. Every
year, hares are imported from Central
Europe for hunting purposes and in 1996
tularemia infected hares from France, Italy,
Austria, Finland, Sweden and Slovakia
were described [5]. 
Importation of infected rabbits has been
attributed to the emergence of tularemia
elsewhere in the Northern Hemisphere. In
the United States in the 1930s, infected rab-
bits from the tularemia endemic states, Mis-
souri and Arkansas, were imported by game
clubs into Massachusetts and liberated [7].
Soon thereafter the first locally acquired
cases of tularemia were reported [3, 7]. 
3.2. Kosovo (2000)
The first report of tularemia in Kosovo
occurred in early 2000, at the end of 10 years
of political crisis and warfare in the region,
when a cluster of patients was identified
with an unusual syndrome of fever, phar-
yngitis and pronounced cervical lymphad-
enopathy [59, 70]. Active case-finding and
serology testing confirmed 327 cases of
tularemia in 21 Kosovo municipalities, with
most cases presenting as oropharyngeal
tularemia. Ingestion of F. tularensis was
suspected as the cause of the outbreak and
a follow-up case-control study indicated
that the outbreak was food and water related
[59]. 
 Retrospective analysis of public health
records back to 1946 showed no prior evi-
dence of tularemia in Kosovo [59]. None-
theless, it is possible that tularemia had
been present in Kosovo prior to the out-
break, but unrecognized in the absence of a
large number of human cases. Both animal
and human tularemia had been reported in
neighboring countries and independent prov-
inces [59]. In 1976, a five-year ecological
study in neighboring Croatia showed that
meadow and common voles were foci of
tularemia in the region [10]. In addition,
tularemia was reported in Turkey in the
1990s, with the majority of human cases
being waterborne (83% of cases) [36, 39]. 
The emergence of tularemia in Kosovo
is linked to the conditions resulting from
war and political crisis [59]. The principal
populations affected by the outbreak lived
in rural farming villages and had fled their
villages in 1999 as a result of ongoing con-
flict, leaving behind unprotected food stor-
age areas, unharvested crops and plowed,
unseeded fields. Untended wells were dam-
aged and contaminated. Returning villagers
noted a population explosion of rodents with
increased rodent activity apparent both in
and around homes. Thus, it is likely that the
war time conditions led to increase in the
local rodent population which allowed for
epizootic spread of tularemia in rodents and
consequent widespread environmental con-
tamination. 
The consequences of war, damaged pub-
lic health care systems, unsound hygiene,
and rodent increase, set the stage for the
emergence and spread of a variety of infec-
tious diseases. Conflict conditions, during
World War II and in Bosnia in 1995, have
led to previous outbreaks of tularemia
[53, 59]. 
3.3. United States (2002)
Tularemia is a recognized disease of the
United States, yet in 2002 it emerged in a
rather unusual and unexpected setting [6,
15, 56]. The site of the outbreak was a Texas
exotic pet facility where a variety of animal
species were housed together and sold to
domestic and international distributors. Thou-
sands of wild-caught prairie dogs were sup-
plied to this facility for commercial purposes
and in July 2002 a large die-off (~ 250 prai-
rie dogs) occurred. Type B was isolated from
the dead prairie dogs at the Texas facility as
well as prairie dogs distributed to the Czech
Republic and to a Texas pet shop.
In this outbreak, the trade of trapping and
selling wild animals as exotic pets allowed
disease emergence. Although both tularemia
and plague had previously been identified
in wild-caught prairie dogs, there were no
quarantine restrictions or testing require-
ments for wild-captured animals, prior to
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their worldwide distribution as pets [2, 13,
47]. Apparently, one or more infected ani-
mals were wild-captured, and the disease
spread by cannibalism as a result of the
unnaturally close contact at the exotic pet
facility. The primary mode of transmission
was ingestion of F. tularensis, as all infected
prairie dogs displayed enlarged submandib-
ular lymph nodes, a hallmark of oropharyn-
geal tularemia. 
In the years prior to this outbreak, the
exotic pet trade had experienced growing
popularity in the United States with unreg-
ulated importation and exportation. Wild
prairie dogs, found throughout the Great
Plains of North America from southern
Canada to just inside Mexico, were col-
lected in the United States between the
months of April and July every year and dis-
tributed to pet stores throughout the country
as well as exported internationally. 
In 2003, the Centers for Disease Control
and Prevention (CDC) and the Food and Drug
Administration (FDA) issued an interim
final rule to establish new restrictions on the
commercial sale of prairie dogs and the
importation of certain exotic species into
the United States as the result of a monkey-
pox outbreak in prairie dogs and subsequent
transmission to human owners [16, 17, 58].
Both the tularemia and monkeypox out-
breaks in prairie dogs served to highlight
the public health dangers associated with
the exotic pet trade, including the speed
with which infected animals can be trans-
ported and the potential for the exotic pet
trade to rapidly introduce non native path-
ogens worldwide. 
3.4. Australia (2002)
Although F. tularensis has long been con-
sidered to cause disease in the Northern
Hemisphere, in 2002 F. tularensis subsp.
novicida emerged in the Southern Hemi-
sphere with the first report of human infec-
tion [69]. A 53-year old man presented with
a swollen toe and swollen inguinal lymph
nodes as a result of a cut received in brack-
ish waters in the Northern Territory of Aus-
tralia. The toe wound yielded an isolate of
F. tularensis subsp. novicida. Because
F. tularensis was not known to be present
in the Southern Hemisphere, molecular
comparison with other Type A, Type B, and
novicida isolates was required before this
isolate could be appropriately identified. 
As in the case of tularemia in Spain, it’s
unlikely that this case represents true emer-
gence of F. tularensis in Australia. F. tula-
rensis subsp. novicida is a less virulent sub-
species of F. tularensis with only a few human
cases of tularemia-like illness described
worldwide. In addition, tularemia was not
recognized as a disease of Australia and
would not have been considered in a clinical
diagnosis. As a result, the identification of
infection due to F. tularensis relied heavily
on the laboratory’s skill and persistence in
identifying the isolate. The availability of
molecular tools and national and interna-
tional collaboration contributed to the accu-
rate identification of F. tularensis in the
Southern Hemisphere. 
Interesting questions remain to be eluci-
dated regarding F. tularensis in Australia,
including how long the organism has been
present in Australia and whether there might
have been previous unrecognized cases.
Nonetheless, this example serves to under-
score the likelihood that F. tularensis is
more widespread than previously thought
and elicits the question of whether other
F. tularensis subspecies are also present in
Australia and elsewhere in the Southern
Hemisphere. 
4. BIOTERRORISM 
AND EMERGENCE
Perhaps the most unique aspect of F. tula-
rensis emergence relates to recent world-
wide concerns regarding the potential use
of biological weapons [40]. Whereas the
previous examples all discussed emergence
with respect to the appearance of the disease
in a new geographic location or population,
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emergence here is used to describe the gen-
eral public and scientific community aware-
ness of tularemia. Due primarily to concerns
over the use of F. tularensis as a biological
weapon, tularemia has emerged as a widely
recognized disease throughout the world.
This is in stark contrast to 10 years prior
when tularemia was considered to be of neg-
ligible public health significance, removed
from the United States nationally notifiable
list of diseases [14] and recognized only by
a few subject matter experts around the
world. 
F. tularensis has been classified as a Cat-
egory A select agent, because of its extreme
infectivity, ease of dissemination, and sub-
stantial capacity to cause illness and death
[20]. Heightened concern regarding the
intentional use of F. tularensis as a bio-
weapon is also due to its previous history
[22]. It was studied by Japanese germ war-
fare units between 1932 and 1945 and the
United States military stockpiled F. tula-
rensis for use as a biological weapon in the
1960’s. In the 1990s, the Soviets were
reported to have produced F. tularensis
strains with engineered resistance to vac-
cines and antibiotics. 
In the scientific research community,
massive amounts of bioterrorism funding
are being directed at Category A agents. As
a result, more researchers are working with
F. tularensis than ever before. Numerous
laboratories in the United States are study-
ing the biology of this organism, with respect
to vaccine development, new diagnostics,
and virulence factors. 
In public health laboratories around the
world, laboratorians are now on the lookout
for potential bioterrorism agents. In coun-
tries where F. tularensis has not previously
been found, microbiologists are now becom-
ing familiar with the protocols to isolate and
identify this organism. Awareness of the
disease has also increased among the med-
ical community. With this enhanced world-
wide surveillance, we may expect to dis-
cover F. tularensis in new and unexpected
places. No doubt bioterrorism awareness
contributed to the first identification of
F. tularensis in the Southern Hemisphere. 
5. DIAGNOSIS AND DETECTION
Identification of natural cases of disease
emergence is limited by our diagnostic tools,
as well as by the skills and attention of cli-
nicians and laboratorians. In this section we
will provide a review of the current diag-
nostics for F. tularensis and their impor-
tance in understanding disease emergence,
as well as some recent advances in diagnos-
tics that may aid in future investigations.
5.1. Culture
Culture recovery and characterization
remains the “gold standard” for laboratory
confirmation of tularemia infection accord-
ing to the CDC. However, this approach has
historically proven itself challenging, par-
ticularly with F. tularensis subsps., Type A
and Type B. F. tularensis subsps., Type A
and Type B, are slow-growing, fastidious
organisms requiring sulfhydryl compounds
and 24–72 h for growth on artificial media
at 37 °C [19, 60]. F. tularensis is also noto-
rious for causing laboratory acquired infec-
tions and has to be handled under BSL-3
conditions [19, 60]. Despite these concerns,
culture provides a conclusive diagnosis of
infection and an invaluable resource for
molecular epidemiology, subtyping and dis-
covery of novel species and subspecies. 
F. tularensis from primary clinical sources
grows well on several media, including
enriched chocolate agar (CA), cysteine heart
agar with 9% chocolatized blood (CHAB),
and buffered charcoal yeast extract (BYCE)
[19, 60]. F. tularensis can be isolated from
nutrient enriched specimens (tissues) on
sheep blood agar (SBA), but CHAB is
strongly recommended for subculture as the
organism will fail to thrive with continued
passage on SBA. Additonally, growth on
CHAB provides for presumptive identifica-
tion of F. tularensis as the organism shows
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characteristic growth on this media (green,
opalescent, raised, shiny colonies at 24–
48 h). Once a pure isolate has been recov-
ered, glycerol fermentation can be used to
differentiate Type A (glycerol fermentation
positive) and Type B (glycerol fermenta-
tion negative). F. tularensis subsp. novicida
is non-fastidious and can be isolated on gen-
eral microbiological agars, including SBA.
Contaminated specimens pose an espe-
cially difficult challenge when attempting
to isolate F. tularensis. Evidence suggests
that some bacteria inhibit F. tularensis growth
[57]. This finding has important implica-
tions when attempting to isolate F. tularen-
sis from a variety of samples that contain
other bacterial species. Recently, an antibi-
otic supplemented CHAB media (CHAB-A)
was shown to significantly improve recov-
ery rates of F. tularensis from tissue sources
contaminated or overgrown by other flora
[57]. In clinical or environmental speci-
mens where mixed flora is likely, the use of
CHAB-A should be considered. 
5.2. Serology 
Serology is the most commonly used lab-
oratory approach for confirmation of sus-
pected disease. However, specific antibody
responses are typically not detectable prior
to two weeks of infection with currently
available tests [9]. Nonetheless, retrospec-
tive serosurveys can be extremely useful for
understanding the timing of disease emer-
gence in a particular area or population.
IgM, IgA and IgG antibodies appear simul-
taneously after initial infection and IgM
antibodies can last for many years. Agglu-
tination based on formalin-killed whole cells
is the standard serology test used for deter-
mining the presence of antibody against
F. tularensis [12]. ELISAs based on LPS or
outer membrane carbohydrate-protein frac-
tions have also been utilized [9, 67]. With
renewed interest in F. tularensis due to bio-
terrorism, we may well expect the identifi-
cation of new diagnostic antigens useful for
early detection and subtyping.
5.3. PCR
A variety of PCR methods have been
described for the detection of F. tularensis
DNA in both clinical and environmental
specimens. PCR can be an invaluable diag-
nostic tool when organisms are noncultiva-
ble or nonviable. The majority of PCR tests
for F. tularensis have been gel-based PCR
assays targeted at the genes encoding the
outer membrane proteins, fopA or tul4 [32,
48, 61]. These PCR assays show good spe-
cificity and allow for rapid detection of F.
tularensis in specimens. The tul4 PCR
assay displays a sensitivity of 75% when
applied to wound specimens from patients
with ulceroglandular tularemia [45].
Advances in PCR detection have been
made with the development of real-time Taq-
Man PCR assays. These assays have increased
specificity and rapidity over gel-based PCR
and can provide added sensitivity when
testing both clinical and environmental
specimens in which the number of organ-
isms is expected to be quite low. A real-time
F. tularensis multitarget TaqMan PCR assay
based on three targets, the ISFtu2 element,
23kDa and tul4 genes was recently described
[66]. In addition to increased sensitivity, a
detection limit of ~ 1 CFU, the multitarget
aspect of this assay has the added advantage
of decreasing the likelihood of false posi-
tives. 
5.4. 16S rDNA sequencing
 Several studies have shown the useful-
ness of 16S rDNA sequence identification
in the diagnostic laboratory, especially as
relates to slow-growing, unusual, and fas-
tidious bacteria [38, 64]. For identifying
true emergence of F. tularensis, in areas
where it has not previously been reported,
16S rDNA sequencing is a particularly use-
ful diagnostic test. 16S rDNA sequencing
played an important role in the first identi-
fication of F. tularensis in the Southern
Hemisphere and also in the tularemia out-
break associated with crayfish in Spain [4,
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69]. For identification of recovered bacte-
rial isolates, the universal 16S rDNA prim-
ers as well as the Francisella specific 16S
rDNA primers, provide good sequence data
[28]. For diagnostic identification of Fran-
cisella spp. in contaminated samples (ticks,
water, field specimens), the Francisella
specific 16S rDNA primers should be con-
sidered [4, 51].
5.5. Molecular subtyping
PCR subtyping assays have been devel-
oped that allow for discriminating F. tula-
rensis subsp., Type A and Type B, in the
absence of a culture [46, 56]. These assays
are gel-based and center on the detection of
differences in amplified product sizes. More
recently, a gel-based PCR assay targeted at
the region of difference 1 (RD1), has been
reported to distinguish between all four sub-
species of F. tularensis, Type A, Type B,
novicida, and mediaasiatica, although eval-
uation of a larger panel of isolates, especially
novicida, will be required before this assay
can be employed routinely for F. tularensis
subtyping [11]. 
Advances have recently been made in
strain differentiation using a variety of molec-
ular techniques including restriction frag-
ment linked polymorphism (RFLP) South-
ern blot, pulsed-field gel electrophoresis
(PFGE) and multi-locus variable number
tandem repeat assays (MLVA) [25, 33, 65].
These techniques will be extremely impor-
tant for detailed molecular epidemiology
studies in the future. With continued devel-
opment and refinement of these techniques,
we can well expect molecular strain differ-
entiation of F. tularensis to play an impor-
tant role in understanding the true basis of
disease emergence. 
6. CONCLUSION 
Renewed scientific and public interest in
the field of tularemia has evolved recently
in large part due to the biothreat potential
of this bacterial agent. Ironically, tularemia
was dropped from the list of nationally
reportable diseases in the United States in
1994 only to be reinstated in 2000. Although
actively investigated in the early 1900’s,
many of the questions posed during that era
are still valid. What are the differences that
account for virulence between Type A and
Type B strains? Where does tularemia per-
sist during quiescent periods? Is there spill-
over between aquatic and terrestrial disease
cycles? What are the environmental factors
that lead to outbreaks in animals and humans?
Natural factors influencing the ecology and
emergence of tularemia are poorly under-
stood but undoubtedly include climate, num-
bers of suitable hosts and vectors, and resist-
ance of hosts to infection. Although these
parameters may be influenced by man, more
immediate outcomes are affected by activ-
ities such as the introduction or movement
of diseased and susceptible hosts. Recent
and novel human outbreaks have served to
heighten the awareness, importance, and
interest in this complex zoonotic disease.
With the aid of current molecular diagnos-
tic tools, tried-and-true bacteriologic meth-
ods, increased clinical recognition, epide-
miologic investigations and an infusion of
research funding, the answers to these ques-
tions are well within our grasp. 
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